These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21953137)

  • 21. Renal function and severity of bright liver. Relationship with insulin resistance, intrarenal resistive index, and glomerular filtration rate.
    Catalano D; Trovato GM; Martines GF; Pirri C; Trovato FM
    Hepatol Int; 2011 Sep; 5(3):822-9. PubMed ID: 21484130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High adenovirus 36 seroprevalence among a population of Hispanic American youth.
    LaVoy EC; Arlinghaus KR; Rooney BV; Gupta P; Atkinson R; Johnston CA
    Int J Adolesc Med Health; 2018 Nov; 33(2):. PubMed ID: 30496137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin receptor-independent upregulation of cellular glucose uptake.
    Krishnapuram R; Kirk-Ballard H; Dhurandhar EJ; Dubuisson O; Messier V; Rabasa-Lhoret R; Hegde V; Aggarwal S; Dhurandhar NV
    Int J Obes (Lond); 2013 Jan; 37(1):146-53. PubMed ID: 22310476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adherence to Mediterranean Diet and Non-Alcoholic Fatty Liver Disease: Effect on Insulin Resistance.
    Baratta F; Pastori D; Polimeni L; Bucci T; Ceci F; Calabrese C; Ernesti I; Pannitteri G; Violi F; Angelico F; Del Ben M
    Am J Gastroenterol; 2017 Dec; 112(12):1832-1839. PubMed ID: 29063908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute effect of infection by adipogenic human adenovirus Ad36.
    Pasarica M; Loiler S; Dhurandhar NV
    Arch Virol; 2008; 153(11):2097-102. PubMed ID: 18830560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Observational Study Suggests That Natural HAdV-36 Infection Decreases Blood Glucose Levels without Affecting Insulin Levels in Obese Young Subjects.
    Matia-Garcia I; Ocampo-Galeana JA; Muñoz-Valle JF; Soñanez-Organis JG; González RA; Guzmán-Guzmán IP; Marino-Ortega LA; Parra-Rojas I
    Viruses; 2024 Jun; 16(6):. PubMed ID: 38932214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case-control study on nutritional risk factors in non-alcoholic fatty liver disease in Indian population.
    Sathiaraj E; Chutke M; Reddy MY; Pratap N; Rao PN; Reddy DN; Raghunath M
    Eur J Clin Nutr; 2011 Apr; 65(4):533-7. PubMed ID: 21346716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.
    Wong VW; Wong GL; Chan RS; Shu SS; Cheung BH; Li LS; Chim AM; Chan CK; Leung JK; Chu WC; Woo J; Chan HL
    J Hepatol; 2018 Dec; 69(6):1349-1356. PubMed ID: 30142427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Non-alcoholic fatty liver disease and its association with clinical and biochemical variables in obese children and adolescents: effect of a one-year intervention on lifestyle].
    Santomauro M; Paoli-Valeri M; Fernández M; Camacho N; Molina Z; Cicchetti R; Valeri L; Dávila de Campagnaro E; Arata-Bellabarba G
    Endocrinol Nutr; 2012; 59(6):346-53. PubMed ID: 22717644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis.
    Hohenester S; Christiansen S; Nagel J; Wimmer R; Artmann R; Denk G; Bischoff M; Bischoff G; Rust C
    Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G329-G338. PubMed ID: 29878845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neglected features of lifestyle: Their relevance in non-alcoholic fatty liver disease.
    Trovato FM; Martines GF; Brischetto D; Trovato G; Catalano D
    World J Hepatol; 2016 Nov; 8(33):1459-1465. PubMed ID: 27957244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative study of overweight and obese patients with nonalcoholic fatty liver disease.
    Aller R; Burgueño Gomez B; Sigüenza R; Fernández-Rodríguez C; Fernández N; Antolín B; Durà M; Pina M; Lorenzo S; García C; de Luis Román D
    Rev Esp Enferm Dig; 2019 Apr; 111(4):256-263. PubMed ID: 30746959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of adenovirus 36 infection with obesity and metabolic markers in humans: a meta-analysis of observational studies.
    Yamada T; Hara K; Kadowaki T
    PLoS One; 2012; 7(7):e42031. PubMed ID: 22848697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Baseline HOMA IR and Circulating FGF21 Levels Predict NAFLD Improvement in Patients Undergoing a Low Carbohydrate Dietary Intervention for Weight Loss: A Prospective Observational Pilot Study.
    Watanabe M; Risi R; Camajani E; Contini S; Persichetti A; Tuccinardi D; Ernesti I; Mariani S; Lubrano C; Genco A; Spera G; Gnessi L; Basciani S
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32708435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calorie-Restricted Mediterranean and Low-Fat Diets Affect Fatty Acid Status in Individuals with Nonalcoholic Fatty Liver Disease.
    Ristic-Medic D; Kovacic M; Takic M; Arsic A; Petrovic S; Paunovic M; Jovicic M; Vucic V
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33374554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease.
    Pais R; Rusu E; Zilisteanu D; Circiumaru A; Micu L; Voiculescu M; Poynard T; Ratziu V
    Eur J Intern Med; 2015 Jan; 26(1):30-6. PubMed ID: 25553983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomised controlled trial of a Mediterranean Dietary Intervention for Adults with Non Alcoholic Fatty Liver Disease (MEDINA): study protocol.
    Papamiltiadous ES; Roberts SK; Nicoll AJ; Ryan MC; Itsiopoulos C; Salim A; Tierney AC
    BMC Gastroenterol; 2016 Feb; 16():14. PubMed ID: 26831892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Difference in lifestyle and metabolic profile of non-alcoholic fatty liver disease with raised alanine amino-transferases between obese and non-overweight subjects.
    Sharma M; Kulkarni A; Kumar P; Nori VB; Jagtap N; Gupta R; Reddy DN; Rao PN
    Sci Rep; 2020 Sep; 10(1):15232. PubMed ID: 32943747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease.
    Lomonaco R; Ortiz-Lopez C; Orsak B; Webb A; Hardies J; Darland C; Finch J; Gastaldelli A; Harrison S; Tio F; Cusi K
    Hepatology; 2012 May; 55(5):1389-97. PubMed ID: 22183689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.
    El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM
    Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.